drugset / Trial / NCT02639598

Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis

NCT02639598

Phase 4 Completed 62 enrolled Taipei Veterans General Hospital, Taiwan
RandomizedParallel-groupOpen-labelTreatment

Summary

Chronic migraine (CM) is a prevalent and devastating disorder with limited therapeutic options. This study explored the efficacy of 10 mg/day flunarizine for CM prophylaxis as compared with 50 mg/day topiramate.

Timeline

Start
2012-06
Primary completion
2014-12
Completion
2015-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Flunarizine Small molecule 10 mg
Comparator Topiramate Small molecule 50 mg

Indications